Recruiting

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

Sponsor:

Endogenex, Inc.

Code:

NCT06267391

Conditions

Type 2 Diabetes Mellitus

Type2diabetes

Diabetes Mellitus, Type 2

Diabetes

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 22 - 70

Healthy Volunteers: Not accepted

Interventions

ReCET Treatment

Sham Procedure

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information